FEDERATED HERMES INC (FHI) Fundamental Analysis & Valuation

NYSE:FHI • US3142111034

Current stock price

56.3 USD
+1.03 (+1.86%)
At close:
56.3 USD
0 (0%)
After Hours:

This FHI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. FHI Profitability Analysis

1.1 Basic Checks

  • FHI had positive earnings in the past year.
  • In the past year FHI had a positive cash flow from operations.
  • FHI had positive earnings in each of the past 5 years.
  • FHI had a positive operating cash flow in each of the past 5 years.
FHI Yearly Net Income VS EBIT VS OCF VS FCFFHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 17.28%, FHI belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
  • FHI has a better Return On Equity (32.18%) than 95.83% of its industry peers.
  • FHI has a Return On Invested Capital of 19.98%. This is amongst the best in the industry. FHI outperforms 95.42% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for FHI is significantly above the industry average of 7.19%.
  • The last Return On Invested Capital (19.98%) for FHI is above the 3 year average (17.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 17.28%
ROE 32.18%
ROIC 19.98%
ROA(3y)14.38%
ROA(5y)13.45%
ROE(3y)26.96%
ROE(5y)25.19%
ROIC(3y)17.87%
ROIC(5y)17.01%
FHI Yearly ROA, ROE, ROICFHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • FHI's Profit Margin of 21.27% is in line compared to the rest of the industry. FHI outperforms 57.92% of its industry peers.
  • In the last couple of years the Profit Margin of FHI has remained more or less at the same level.
  • With a Operating Margin value of 28.95%, FHI perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
  • FHI's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of FHI (95.54%) is better than 96.25% of its industry peers.
  • In the last couple of years the Gross Margin of FHI has remained more or less at the same level.
Industry RankSector Rank
OM 28.95%
PM (TTM) 21.27%
GM 95.54%
OM growth 3Y3.48%
OM growth 5Y0.05%
PM growth 3Y10.43%
PM growth 5Y-0.36%
GM growth 3Y-0.16%
GM growth 5Y-0.14%
FHI Yearly Profit, Operating, Gross MarginsFHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

9

2. FHI Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for FHI has been reduced compared to 1 year ago.
  • The number of shares outstanding for FHI has been reduced compared to 5 years ago.
  • FHI has a better debt/assets ratio than last year.
FHI Yearly Shares OutstandingFHI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
FHI Yearly Total Debt VS Total AssetsFHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • FHI has an Altman-Z score of 5.28. This indicates that FHI is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.28, FHI belongs to the best of the industry, outperforming 87.08% of the companies in the same industry.
  • FHI has a debt to FCF ratio of 1.18. This is a very positive value and a sign of high solvency as it would only need 1.18 years to pay back of all of its debts.
  • The Debt to FCF ratio of FHI (1.18) is better than 87.50% of its industry peers.
  • FHI has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • FHI has a better Debt to Equity ratio (0.29) than 73.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 1.18
Altman-Z 5.28
ROIC/WACCN/A
WACCN/A
FHI Yearly LT Debt VS Equity VS FCFFHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • FHI has a Current Ratio of 2.75. This indicates that FHI is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of FHI (2.75) is better than 80.83% of its industry peers.
  • FHI has a Quick Ratio of 2.75. This indicates that FHI is financially healthy and has no problem in meeting its short term obligations.
  • FHI has a better Quick ratio (2.75) than 80.83% of its industry peers.
Industry RankSector Rank
Current Ratio 2.75
Quick Ratio 2.75
FHI Yearly Current Assets VS Current LiabilitesFHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

4

3. FHI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 61.13% over the past year.
  • FHI shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.87% yearly.
  • The Revenue for FHI has decreased by -10.86% in the past year. This is quite bad
  • The Revenue has been growing slightly by 4.57% on average over the past years.
EPS 1Y (TTM)61.13%
EPS 3Y20.61%
EPS 5Y9.87%
EPS Q2Q%33.65%
Revenue 1Y (TTM)-10.86%
Revenue growth 3Y7.9%
Revenue growth 5Y4.57%
Sales Q2Q%13.69%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.75% on average over the next years.
  • Based on estimates for the next years, FHI will show a small growth in Revenue. The Revenue will grow by 1.75% on average per year.
EPS Next Y1.92%
EPS Next 2Y6.2%
EPS Next 3Y7.49%
EPS Next 5Y5.75%
Revenue Next Year9.7%
Revenue Next 2Y6.99%
Revenue Next 3Y5.29%
Revenue Next 5Y1.75%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
FHI Yearly Revenue VS EstimatesFHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
FHI Yearly EPS VS EstimatesFHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

6

4. FHI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.95, which indicates a very decent valuation of FHI.
  • Based on the Price/Earnings ratio, FHI is valued a bit cheaper than the industry average as 61.25% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.18. FHI is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 10.75, the valuation of FHI can be described as very reasonable.
  • FHI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FHI is cheaper than 65.42% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 37.96. FHI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.95
Fwd PE 10.75
FHI Price Earnings VS Forward Price EarningsFHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 91.25% of the companies in the same industry are more expensive than FHI, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, FHI is valued a bit cheaper than 67.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.49
EV/EBITDA 6.72
FHI Per share dataFHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates FHI does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of FHI may justify a higher PE ratio.
PEG (NY)5.69
PEG (5Y)1.11
EPS Next 2Y6.2%
EPS Next 3Y7.49%

4

5. FHI Dividend Analysis

5.1 Amount

  • FHI has a Yearly Dividend Yield of 2.39%.
  • Compared to an average industry Dividend Yield of 6.65, FHI has a dividend in line with its industry peers.
  • FHI's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.39%

5.2 History

  • The dividend of FHI decreases each year by -8.56%.
  • FHI has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-8.56%
Div Incr Years0
Div Non Decr Years0
FHI Yearly Dividends per shareFHI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • FHI pays out 27.23% of its income as dividend. This is a sustainable payout ratio.
DP27.23%
EPS Next 2Y6.2%
EPS Next 3Y7.49%
FHI Yearly Income VS Free CF VS DividendFHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
FHI Dividend Payout.FHI Dividend Payout, showing the Payout Ratio.FHI Dividend Payout.PayoutRetained Earnings

FHI Fundamentals: All Metrics, Ratios and Statistics

FEDERATED HERMES INC

NYSE:FHI (4/13/2026, 8:26:25 PM)

After market: 56.3 0 (0%)

56.3

+1.03 (+1.86%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)01-29
Earnings (Next)04-30
Inst Owners94.09%
Inst Owner Change0.15%
Ins Owners3.5%
Ins Owner Change1.25%
Market Cap4.27B
Revenue(TTM)1.81B
Net Income(TTM)385.17M
Analysts68.33
Price Target57.94 (2.91%)
Short Float %4.78%
Short Ratio4.61
Dividend
Industry RankSector Rank
Dividend Yield 2.39%
Yearly Dividend1.33
Dividend Growth(5Y)-8.56%
DP27.23%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-06
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.71%
Min EPS beat(2)15.34%
Max EPS beat(2)18.07%
EPS beat(4)4
Avg EPS beat(4)20.1%
Min EPS beat(4)12.16%
Max EPS beat(4)34.82%
EPS beat(8)7
Avg EPS beat(8)2.87%
EPS beat(12)10
Avg EPS beat(12)3.57%
EPS beat(16)12
Avg EPS beat(16)2.96%
Revenue beat(2)2
Avg Revenue beat(2)3.59%
Min Revenue beat(2)2.38%
Max Revenue beat(2)4.79%
Revenue beat(4)2
Avg Revenue beat(4)1.54%
Min Revenue beat(4)-0.52%
Max Revenue beat(4)4.79%
Revenue beat(8)3
Avg Revenue beat(8)0.31%
Revenue beat(12)4
Avg Revenue beat(12)0.5%
Revenue beat(16)7
Avg Revenue beat(16)5.78%
PT rev (1m)2.16%
PT rev (3m)9.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.05%
EPS NY rev (1m)1.77%
EPS NY rev (3m)3.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.92%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)2.49%
Valuation
Industry RankSector Rank
PE 10.95
Fwd PE 10.75
P/S 2.36
P/FCF 14.49
P/OCF 14.36
P/B 3.57
P/tB 320.17
EV/EBITDA 6.72
EPS(TTM)5.14
EY9.13%
EPS(NY)5.24
Fwd EY9.31%
FCF(TTM)3.88
FCFY6.9%
OCF(TTM)3.92
OCFY6.96%
SpS23.88
BVpS15.78
TBVpS0.18
PEG (NY)5.69
PEG (5Y)1.11
Graham Number42.72
Profitability
Industry RankSector Rank
ROA 17.28%
ROE 32.18%
ROCE 27.37%
ROIC 19.98%
ROICexc 32.13%
ROICexgc 5250.42%
OM 28.95%
PM (TTM) 21.27%
GM 95.54%
FCFM 16.27%
ROA(3y)14.38%
ROA(5y)13.45%
ROE(3y)26.96%
ROE(5y)25.19%
ROIC(3y)17.87%
ROIC(5y)17.01%
ROICexc(3y)27.56%
ROICexc(5y)25.17%
ROICexgc(3y)2493.83%
ROICexgc(5y)1778.86%
ROCE(3y)24.48%
ROCE(5y)23.31%
ROICexgc growth 3Y82.35%
ROICexgc growth 5Y66.55%
ROICexc growth 3Y13.21%
ROICexc growth 5Y7.38%
OM growth 3Y3.48%
OM growth 5Y0.05%
PM growth 3Y10.43%
PM growth 5Y-0.36%
GM growth 3Y-0.16%
GM growth 5Y-0.14%
F-Score7
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 1.18
Debt/EBITDA 0.64
Cap/Depr 12.41%
Cap/Sales 0.15%
Interest Coverage 44.41
Cash Conversion 54.41%
Profit Quality 76.48%
Current Ratio 2.75
Quick Ratio 2.75
Altman-Z 5.28
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)19.95%
Cap/Depr(5y)22.03%
Cap/Sales(3y)0.3%
Cap/Sales(5y)0.4%
Profit Quality(3y)105.52%
Profit Quality(5y)103.72%
High Growth Momentum
Growth
EPS 1Y (TTM)61.13%
EPS 3Y20.61%
EPS 5Y9.87%
EPS Q2Q%33.65%
EPS Next Y1.92%
EPS Next 2Y6.2%
EPS Next 3Y7.49%
EPS Next 5Y5.75%
Revenue 1Y (TTM)-10.86%
Revenue growth 3Y7.9%
Revenue growth 5Y4.57%
Sales Q2Q%13.69%
Revenue Next Year9.7%
Revenue Next 2Y6.99%
Revenue Next 3Y5.29%
Revenue Next 5Y1.75%
EBIT growth 1Y-0.99%
EBIT growth 3Y11.66%
EBIT growth 5Y4.62%
EBIT Next Year11.24%
EBIT Next 3Y7.03%
EBIT Next 5Y1.94%
FCF growth 1Y-14%
FCF growth 3Y-2.68%
FCF growth 5Y-3.92%
OCF growth 1Y-14.2%
OCF growth 3Y-2.82%
OCF growth 5Y-4.44%

FEDERATED HERMES INC / FHI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for FEDERATED HERMES INC?

ChartMill assigns a fundamental rating of 7 / 10 to FHI.


Can you provide the valuation status for FEDERATED HERMES INC?

ChartMill assigns a valuation rating of 6 / 10 to FEDERATED HERMES INC (FHI). This can be considered as Fairly Valued.


Can you provide the profitability details for FEDERATED HERMES INC?

FEDERATED HERMES INC (FHI) has a profitability rating of 8 / 10.


What is the valuation of FEDERATED HERMES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FEDERATED HERMES INC (FHI) is 10.95 and the Price/Book (PB) ratio is 3.57.


What is the financial health of FEDERATED HERMES INC (FHI) stock?

The financial health rating of FEDERATED HERMES INC (FHI) is 9 / 10.